Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Early Detection & Prognosis: Guest, Dr. Jesse Berry

Early Detection & Prognosis: Guest, Dr. Jesse Berry

FromThe Eye Believe Podcast


Early Detection & Prognosis: Guest, Dr. Jesse Berry

FromThe Eye Believe Podcast

ratings:
Length:
35 minutes
Released:
Nov 20, 2023
Format:
Podcast episode

Description

Join A Cure in Sight to interview Dr. Jesse Berry for this episode chosen and sponsored by Castle Biosciences - the topic? Eye exams and early detection - does finding OM earlier REALLY make a difference? In what ways?

Jesse L. Berry, MD is a board-certified ophthalmologist with subspecialty training in ocular oncology. She received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the Assistant Chief of Service at the Los Angeles County Medical Center. She completed a fellowship in Ocular Oncology at Children’s Hospital Los Angeles.
She currently serves as the Vice Chair for Academic Affairs for the Department of Surgery and Director of Ocular Oncology at the Vision Center, CHLA. Dr. Berry actively treats patients with retinoblastoma, uveal melanoma, intraocular and ocular surface tumors. She is active academically within the broader field of ophthalmology and ocular oncology. She is the Vice President for the International Society of Ocular Oncology and
was the conference chair for the biennial meeting in Los Angeles in 2019. She is an active advocate for mentorship and opportunities for young ophthalmologists. As such, she is a member of the Young Ophthalmologist committee through the American Academy of Ophthalmology and co-leads the committee for young ophthalmic oncologists and pathologists (YOOPs). Dr. Berry is active within the Women in Ophthalmology organization and is the founder of WOO, Women in Ocular Oncology.
As a physician-scientist, Dr. Berry studies outcomes for retinoblastoma, melanoma and other tumors. Her main interest is the development of the aqueous humor as a liquid biopsy for retinoblastoma and other intraocular disease. She was awarded a K08 from the National Cancer Institute of the National Institute of Health in 2018 to further study this.
In 2019 she was promoted to Associate Professor of Ophthalmology, Clinical Scholar, a special distinction provided by USC. In 2021 she was awarded the prestigious USC Faculty Mentoring Award. She currently holds the USC Berle & Lucy Adams Chair in Cancer Research.
ANNOUNCEMENTS:
5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! Start your team and bring your community to get involved! Highest record for registrations is 306! Who can top it!? Fundraisers have a record of $30K+ in Palo Alto–who can help beat that!? 
December 9, Dallas FTW TX
https://runsignup.com/Race/TX/FortWorth/LookinForACureFortWorth
December 10, Houston, TX
https://runsignup.com/Race/TX/Houston/LookinForACureHouston
January 20, 2024 Orlando FL
https://runsignup.com/Race/FL/Orlando/LookinForACureTampa
January 21, 2024, Miami FL
https://runsignup.com/Race/FL/Miami/LookinForACureMiami
Head to our site to register for a 5K Lookin’ for a Cure near you for the remainder of the year!!
www.lookinforacure.org

Subscribe to the newsletter to stay in the know
Newsletter link
Email contact@acureinsight.org for questions regarding any upcoming events!
*********
Be sure to follow us on Facebook, Twitter, Linked In, or  Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!
*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more!

Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure.

Contribute via  PAYPAL OR VENMO or reach out directly to contact@acureinsight.org 
Released:
Nov 20, 2023
Format:
Podcast episode

Titles in the series (100)

Sharing information and insights on treatment, research, and living with ocular melanoma.